Indications for the use of human chorionic gonadotropic hormone for the management of infertility in hypogonadal men

Indications for the use of human chorionic gonadotropic hormone for the management of infertility in hypogonadal men

Hypogonadism among men desiring fertility preservation presents a unique challenge to physicians. Over the past decade the number of younger men with hypogonadism has increased dramatically. These men are often treated with testosterone replacement therapy (TRT) which can result in azoospermia and p...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Translational andrology and urology 2018-07, Vol.7 (Suppl 3), p.S348-S352
Hauptverfasser: Lee, John Alden, Ramasamy, Ranjith
Format: Artikel
Sprache:eng
Schlagworte:
Review
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page S352
container_issue Suppl 3
container_start_page S348
container_title Translational andrology and urology
container_volume 7
creator Lee, John Alden
Ramasamy, Ranjith
description Hypogonadism among men desiring fertility preservation presents a unique challenge to physicians. Over the past decade the number of younger men with hypogonadism has increased dramatically. These men are often treated with testosterone replacement therapy (TRT) which can result in azoospermia and potentially infertility. Human chorionic gonadotropin (hCG) therapy can help re-establish or maintain spermatogenesis in hypogonadal men. We review the indications, and discuss the current evidence for the role of hCG in men with hypogonadisms.
doi_str_mv 10.21037/tau.2018.04.11
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6087849</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2097594479</sourcerecordid><originalsourceid>FETCH-LOGICAL-c393t-1dcede2ca3d9683fc4af88d00d824720dc1bcb8b0c3894dace8fda71e3e079023</originalsourceid><addsrcrecordid>eNpVkc1PGzEQxa2qqCDKmVvlYy8J4w-y9gWpQqUgIXGhZ8uxZ7Oudu1ge5Hy3-MAjeA0M57fe2PpEXLOYMkZiO6i2nnJgaklyCVjX8gJ51ws5Eqzrx_6Y3JWyj8AYFwouWLfyLEAdqm5ZCek3kUfnK0hxUL7lGkdkM4FaerpME82Ujek3LbB0U2K1qea07YN7XVKEQ-ahtoNThjrXhpij7mGMdRd6-mw26ZXtR1pQ76To96OBc_e6yn5e_P78fp2cf_w5-761_3CCS3qgnmHHrmzwuuVEr2TtlfKA3jFZcfBO7Z2a7UGJ5SW3jpUvbcdQ4HQaeDilFy9-W7n9YTNLdZsR7PNYbJ5Z5IN5vMmhsFs0rNZgeqU1M3g57tBTk8zlmqmUByOo42Y5mI46O5SS9nt0Ys31OVUSsb-cIaBeY3LtLjMPi4D0jDWFD8-_u7A_w9HvAB1ppUy</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2097594479</pqid></control><display><type>article</type><title>Indications for the use of human chorionic gonadotropic hormone for the management of infertility in hypogonadal men</title><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Lee, John Alden ; Ramasamy, Ranjith</creator><creatorcontrib>Lee, John Alden ; Ramasamy, Ranjith</creatorcontrib><description>Hypogonadism among men desiring fertility preservation presents a unique challenge to physicians. Over the past decade the number of younger men with hypogonadism has increased dramatically. These men are often treated with testosterone replacement therapy (TRT) which can result in azoospermia and potentially infertility. Human chorionic gonadotropin (hCG) therapy can help re-establish or maintain spermatogenesis in hypogonadal men. We review the indications, and discuss the current evidence for the role of hCG in men with hypogonadisms.</description><identifier>ISSN: 2223-4691</identifier><identifier>ISSN: 2223-4683</identifier><identifier>EISSN: 2223-4691</identifier><identifier>DOI: 10.21037/tau.2018.04.11</identifier><identifier>PMID: 30159241</identifier><language>eng</language><publisher>China: AME Publishing Company</publisher><subject>Review</subject><ispartof>Translational andrology and urology, 2018-07, Vol.7 (Suppl 3), p.S348-S352</ispartof><rights>2018 Translational Andrology and Urology. All rights reserved. 2018 Translational Andrology and Urology.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c393t-1dcede2ca3d9683fc4af88d00d824720dc1bcb8b0c3894dace8fda71e3e079023</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6087849/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6087849/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30159241$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lee, John Alden</creatorcontrib><creatorcontrib>Ramasamy, Ranjith</creatorcontrib><title>Indications for the use of human chorionic gonadotropic hormone for the management of infertility in hypogonadal men</title><title>Translational andrology and urology</title><addtitle>Transl Androl Urol</addtitle><description>Hypogonadism among men desiring fertility preservation presents a unique challenge to physicians. Over the past decade the number of younger men with hypogonadism has increased dramatically. These men are often treated with testosterone replacement therapy (TRT) which can result in azoospermia and potentially infertility. Human chorionic gonadotropin (hCG) therapy can help re-establish or maintain spermatogenesis in hypogonadal men. We review the indications, and discuss the current evidence for the role of hCG in men with hypogonadisms.</description><subject>Review</subject><issn>2223-4691</issn><issn>2223-4683</issn><issn>2223-4691</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNpVkc1PGzEQxa2qqCDKmVvlYy8J4w-y9gWpQqUgIXGhZ8uxZ7Oudu1ge5Hy3-MAjeA0M57fe2PpEXLOYMkZiO6i2nnJgaklyCVjX8gJ51ws5Eqzrx_6Y3JWyj8AYFwouWLfyLEAdqm5ZCek3kUfnK0hxUL7lGkdkM4FaerpME82Ujek3LbB0U2K1qea07YN7XVKEQ-ahtoNThjrXhpij7mGMdRd6-mw26ZXtR1pQ76To96OBc_e6yn5e_P78fp2cf_w5-761_3CCS3qgnmHHrmzwuuVEr2TtlfKA3jFZcfBO7Z2a7UGJ5SW3jpUvbcdQ4HQaeDilFy9-W7n9YTNLdZsR7PNYbJ5Z5IN5vMmhsFs0rNZgeqU1M3g57tBTk8zlmqmUByOo42Y5mI46O5SS9nt0Ys31OVUSsb-cIaBeY3LtLjMPi4D0jDWFD8-_u7A_w9HvAB1ppUy</recordid><startdate>201807</startdate><enddate>201807</enddate><creator>Lee, John Alden</creator><creator>Ramasamy, Ranjith</creator><general>AME Publishing Company</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>201807</creationdate><title>Indications for the use of human chorionic gonadotropic hormone for the management of infertility in hypogonadal men</title><author>Lee, John Alden ; Ramasamy, Ranjith</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c393t-1dcede2ca3d9683fc4af88d00d824720dc1bcb8b0c3894dace8fda71e3e079023</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Review</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lee, John Alden</creatorcontrib><creatorcontrib>Ramasamy, Ranjith</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Translational andrology and urology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lee, John Alden</au><au>Ramasamy, Ranjith</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Indications for the use of human chorionic gonadotropic hormone for the management of infertility in hypogonadal men</atitle><jtitle>Translational andrology and urology</jtitle><addtitle>Transl Androl Urol</addtitle><date>2018-07</date><risdate>2018</risdate><volume>7</volume><issue>Suppl 3</issue><spage>S348</spage><epage>S352</epage><pages>S348-S352</pages><issn>2223-4691</issn><issn>2223-4683</issn><eissn>2223-4691</eissn><abstract>Hypogonadism among men desiring fertility preservation presents a unique challenge to physicians. Over the past decade the number of younger men with hypogonadism has increased dramatically. These men are often treated with testosterone replacement therapy (TRT) which can result in azoospermia and potentially infertility. Human chorionic gonadotropin (hCG) therapy can help re-establish or maintain spermatogenesis in hypogonadal men. We review the indications, and discuss the current evidence for the role of hCG in men with hypogonadisms.</abstract><cop>China</cop><pub>AME Publishing Company</pub><pmid>30159241</pmid><doi>10.21037/tau.2018.04.11</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2223-4691
ispartof Translational andrology and urology, 2018-07, Vol.7 (Suppl 3), p.S348-S352
issn 2223-4691
2223-4683
2223-4691
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6087849
source EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects Review
title Indications for the use of human chorionic gonadotropic hormone for the management of infertility in hypogonadal men
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T01%3A01%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Indications%20for%20the%20use%20of%20human%20chorionic%20gonadotropic%20hormone%20for%20the%20management%20of%20infertility%20in%20hypogonadal%20men&rft.jtitle=Translational%20andrology%20and%20urology&rft.au=Lee,%20John%20Alden&rft.date=2018-07&rft.volume=7&rft.issue=Suppl%203&rft.spage=S348&rft.epage=S352&rft.pages=S348-S352&rft.issn=2223-4691&rft.eissn=2223-4691&rft_id=info:doi/10.21037/tau.2018.04.11&rft_dat=%3Cproquest_pubme%3E2097594479%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2097594479&rft_id=info:pmid/30159241&rfr_iscdi=true